These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 1522454

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS.
    Fauler G, Leis HJ, Huber E, Schellauf C, Kerbl R, Urban C, Gleispach H.
    J Mass Spectrom; 1997 May; 32(5):507-14. PubMed ID: 9180052
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
    Sato Y, Hanai J, Takasugi N, Takeda T.
    Tohoku J Exp Med; 1986 Oct; 150(2):169-74. PubMed ID: 3810642
    [Abstract] [Full Text] [Related]

  • 6. False positive results in a neuroblastoma screening programme.
    Bell S, Parker L, Craft AW, Dale G, McGill AC, Seviour J, Cole M, Smith J.
    Med Pediatr Oncol; 1994 Oct; 22(3):181-6. PubMed ID: 8272007
    [Abstract] [Full Text] [Related]

  • 7. Seasonal variations in vanillylmandelic acid and homovanillic acid in infants' urine.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1987 Jun; 17(2):151-5. PubMed ID: 3613139
    [Abstract] [Full Text] [Related]

  • 8. Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.
    Sadilkova K, Dugaw K, Benjamin D, Jack RM.
    Clin Chim Acta; 2013 Sep 23; 424():253-7. PubMed ID: 23830883
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Simultaneous measurement of VMA and HVA in 24-hour urine samples.
    Harr R.
    Clin Lab Sci; 1991 Sep 23; 4(4):237-41. PubMed ID: 10149424
    [Abstract] [Full Text] [Related]

  • 12. Assessment of the diurnal variations in urinary homovanillic and vanillylmandelic acid excretion for the diagnosis and follow-up of patients with neuroblastoma.
    Tuchman M, Robison LL, Maynard RC, Ramnaraine ML, Krivit W.
    Clin Biochem; 1985 Jun 23; 18(3):176-9. PubMed ID: 4039636
    [Abstract] [Full Text] [Related]

  • 13. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
    Tuchman M, Ramnaraine ML, Woods WG, Krivit W.
    Pediatrics; 1987 Feb 23; 79(2):203-5. PubMed ID: 3808793
    [Abstract] [Full Text] [Related]

  • 14. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1986 Dec 23; 16(4):351-5. PubMed ID: 3795531
    [Abstract] [Full Text] [Related]

  • 15. Urinary creatinine adjusted reference ranges for homovanillic and vanillylmandelic acid in children and adults.
    Cole M, Craft AW, Parker L, Bell S, Seviour JA, McGill AC, Dale G.
    Clin Chim Acta; 1995 Apr 30; 236(1):19-32. PubMed ID: 7664463
    [Abstract] [Full Text] [Related]

  • 16. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
    Tuchman M, Morris CL, Ramnaraine ML, Bowers LD, Krivit W.
    Pediatrics; 1985 Feb 30; 75(2):324-8. PubMed ID: 3969335
    [Abstract] [Full Text] [Related]

  • 17. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1987 Sep 30; 17(3):221-8. PubMed ID: 3669365
    [Abstract] [Full Text] [Related]

  • 18. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A, Zaizen Y, Ikeda K, Suita S, Ohgami H, Nagahara N, Sera Y, Akiyama H, Kawakami K, Uchino J.
    Cancer; 1991 Nov 01; 68(9):2037-44. PubMed ID: 1913552
    [Abstract] [Full Text] [Related]

  • 19. Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors.
    Sawada T.
    Pediatr Hematol Oncol; 1997 Nov 01; 14(4):291-3. PubMed ID: 9211532
    [No Abstract] [Full Text] [Related]

  • 20. Neuroblastoma screening: labeling of HVA and VMA for stable isotope dilution gas chromatography-mass spectrometry.
    Gleispach H, Huber E, Fauler G, Kerbl R, Urban C, Leis HJ.
    Nutrition; 1995 Nov 01; 11(5 Suppl):604-6. PubMed ID: 8748233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.